Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Stock Information for Solana Company

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Solana Company

Solana Company Reports Third Quarter 2025 Financial Results
Solana Company to Release Third Quarter Operating Results on November 18, 2025
Solana Company Announces Intent to Tokenize HSDT Shares on Superstate's Opening Bell
Clear Street's Disruptive Technology Conference Convenes this Month in Palm Beach
Solana Company (NASDAQ: HSDT) Releases Investor Update
Solana Company Files Application to Cease to Be a Reporting Issuer in Canada
Solana Company (NASDAQ: HSDT) Releases Investor Update
CORRECTION - Solana Company Announces Updated SOL Holdings and Industry Leading Staking Yield

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.